Delivery Order SPE2DB22D3501-SPE2DB24FVN44

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $4,097.22 to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is for the pharmaceutical product Qsymia 7.5 mg-46 mg capsules, and has a completion date of May 7, 2024. Amerisourcebergen, as a major supplier of pharmaceuticals and medical supplies to federal agencies, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a Delivery Order valued at $4,479.23 for the provision of the prescription drug QSYMIA 3.75 MG-23 MG CAPSULE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 29, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,708.20, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of the pharmaceutical product QSYMIA 3.75MG-23MG 30S. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $6,070.08, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of 4564800154 QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,274.90, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
This federal contract award is a delivery order (SPE2DB25FQAWX) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.81 firm fixed-price contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules. The contract has a completion date of December 3, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of the prescription drug Qsymia 3.75 mg-23 mg capsules, in 30-count packages, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,544.45 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical drug QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,466.24, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVN44
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is a Delivery Order valued at $5,410.22 for the supply of the prescription medication QSYMIA 3.75 MG-23 MG CAPSULE 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract was awarded on a full and open competition basis without any set-aside designation.

Generated 8/2/24, 9:48 AM